Spread the loveThe journey from GIMP 2.x to GIMP 3.0 has been a long and transformative path, spanning nearly two decades and ...
Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...
D Molecular Therapeutics, Inc. ( (FDMT) ) has released its Q3 earnings. Here is a breakdown of the information 4D Molecular Therapeutics, Inc.
Google Docs users rejoice, Google's Imagen 3, the tech giant's most advanced AI text-to-image generator, is now rolling out ...
High-cost markets see renewed leases, while some push for premium office spaces. Leasing volumes across the Asia-Pacific ...